160 related articles for article (PubMed ID: 29684792)
1. Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach.
Heerma van Voss MR; Kammers K; Vesuna F; Brilliant J; Bergman Y; Tantravedi S; Wu X; Cole RN; Holland A; van Diest PJ; Raman V
Transl Oncol; 2018 Jun; 11(3):755-763. PubMed ID: 29684792
[TBL] [Abstract][Full Text] [Related]
2. Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.
Heerma van Voss MR; Vesuna F; Bol GM; Afzal J; Tantravedi S; Bergman Y; Kammers K; Lehar M; Malek R; Ballew M; Ter Hoeve N; Abou D; Thorek D; Berlinicke C; Yazdankhah M; Sinha D; Le A; Abrahams R; Tran PT; van Diest PJ; Raman V
Oncogene; 2018 Jan; 37(1):63-74. PubMed ID: 28869602
[TBL] [Abstract][Full Text] [Related]
3. RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma.
Wilky BA; Kim C; McCarty G; Montgomery EA; Kammers K; DeVine LR; Cole RN; Raman V; Loeb DM
Oncogene; 2016 May; 35(20):2574-83. PubMed ID: 26364611
[TBL] [Abstract][Full Text] [Related]
4. RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3.
Xie M; Vesuna F; Tantravedi S; Bol GM; Heerma van Voss MR; Nugent K; Malek R; Gabrielson K; van Diest PJ; Tran PT; Raman V
Cancer Res; 2016 Nov; 76(21):6340-6350. PubMed ID: 27634756
[TBL] [Abstract][Full Text] [Related]
5. Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33.
Tantravedi S; Vesuna F; Winnard PT; Martin A; Lim M; Eberhart CG; Berlinicke C; Raabe E; van Diest PJ; Raman V
Transl Oncol; 2019 Jan; 12(1):96-105. PubMed ID: 30292066
[TBL] [Abstract][Full Text] [Related]
6. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
Bol GM; Vesuna F; Xie M; Zeng J; Aziz K; Gandhi N; Levine A; Irving A; Korz D; Tantravedi S; Heerma van Voss MR; Gabrielson K; Bordt EA; Polster BM; Cope L; van der Groep P; Kondaskar A; Rudek MA; Hosmane RS; van der Wall E; van Diest PJ; Tran PT; Raman V
EMBO Mol Med; 2015 May; 7(5):648-69. PubMed ID: 25820276
[TBL] [Abstract][Full Text] [Related]
7. RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2.
Vesuna F; Akhrymuk I; Smith A; Winnard PT; Lin SC; Panny L; Scharpf R; Kehn-Hall K; Raman V
Front Microbiol; 2022; 13():959577. PubMed ID: 36090095
[TBL] [Abstract][Full Text] [Related]
8. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.
Xie M; Vesuna F; Botlagunta M; Bol GM; Irving A; Bergman Y; Hosmane RS; Kato Y; Winnard PT; Raman V
Oncotarget; 2015 Oct; 6(30):29901-13. PubMed ID: 26337079
[TBL] [Abstract][Full Text] [Related]
9. Role of DDX3 in the pathogenesis of inflammatory bowel disease.
Tantravedi S; Vesuna F; Winnard PT; Van Voss MRH; Van Diest PJ; Raman V
Oncotarget; 2017 Dec; 8(70):115280-115289. PubMed ID: 29383159
[TBL] [Abstract][Full Text] [Related]
10. RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2.
Vesuna F; Akhrymuk I; Smith A; Winnard PT; Lin SC; Scharpf R; Kehn-Hall K; Raman V
bioRxiv; 2022 Mar; ():. PubMed ID: 35262079
[TBL] [Abstract][Full Text] [Related]
11. Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level.
Çelik H; Sajwan KP; Selvanathan SP; Marsh BJ; Pai AV; Kont YS; Han J; Minas TZ; Rahim S; Erkizan HV; Toretsky JA; Üren A
Mol Cell Biol; 2015 Sep; 35(18):3145-62. PubMed ID: 26149384
[TBL] [Abstract][Full Text] [Related]
12. Targeting RNA helicase DDX3 in stem cell maintenance and teratoma formation.
Kerr CL; Bol GM; Vesuna F; Raman V
Genes Cancer; 2019 Feb; 10(1-2):11-20. PubMed ID: 30899416
[TBL] [Abstract][Full Text] [Related]
13. A double-edged function of DDX3, as an oncogene or tumor suppressor, in cancer progression (Review).
He Y; Zhang D; Yang Y; Wang X; Zhao X; Zhang P; Zhu H; Xu N; Liang S
Oncol Rep; 2018 Mar; 39(3):883-892. PubMed ID: 29328432
[TBL] [Abstract][Full Text] [Related]
14. RNA Helicase DDX3: A Double-Edged Sword for Viral Replication and Immune Signaling.
Hernández-Díaz T; Valiente-Echeverría F; Soto-Rifo R
Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34204859
[TBL] [Abstract][Full Text] [Related]
15. DDX3 localizes to the centrosome and prevents multipolar mitosis by epigenetically and translationally modulating p53 expression.
Chen WJ; Wang WT; Tsai TY; Li HK; Lee YW
Sci Rep; 2017 Aug; 7(1):9411. PubMed ID: 28842590
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways.
Zhao L; Mao Y; Zhou J; Zhao Y; Cao Y; Chen X
Am J Cancer Res; 2016; 6(2):387-402. PubMed ID: 27186411
[TBL] [Abstract][Full Text] [Related]
17. The DEAD-box RNA helicase DDX3 interacts with DDX5, co-localizes with it in the cytoplasm during the G2/M phase of the cycle, and affects its shuttling during mRNP export.
Choi YJ; Lee SG
J Cell Biochem; 2012 Mar; 113(3):985-96. PubMed ID: 22034099
[TBL] [Abstract][Full Text] [Related]
18. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
[TBL] [Abstract][Full Text] [Related]
19. DDX3 Interacts with Influenza A Virus NS1 and NP Proteins and Exerts Antiviral Function through Regulation of Stress Granule Formation.
Thulasi Raman SN; Liu G; Pyo HM; Cui YC; Xu F; Ayalew LE; Tikoo SK; Zhou Y
J Virol; 2016 Jan; 90(7):3661-75. PubMed ID: 26792746
[TBL] [Abstract][Full Text] [Related]
20. In vitro anti-cancer activity of doxorubicin against human RNA helicase, DDX3.
Botlagunta M; Kollapalli B; Kakarla L; Gajarla SP; Gade SP; Dadi CL; Penumadu A; Javeed S
Bioinformation; 2016; 12(7):347-353. PubMed ID: 28246464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
